Title:
医薬組成物、その製造方法及び使用
Document Type and Number:
Japanese Patent JP7095108
Kind Code:
B2
Abstract:
The present disclosure belongs to the field of pharmaceutical preparations, and discloses a pharmaceutical composition and a preparation method therefor and uses thereof. The pharmaceutical composition comprising EGFR inhibitor (C-005) and the pharmaceutical tablets prepared therefrom of the present disclosure are suitable for the treatment of cancer, preferably lung cancer, particularly non-small cell lung cancer.
Inventors:
Chiachuan Wu
Application Number:
JP2020551317A
Publication Date:
July 04, 2022
Filing Date:
March 23, 2018
Export Citation:
Assignee:
Woothy Shoan Liang Biotechnology Company, Limited
International Classes:
A61K31/506; A61K9/20; A61K47/02; A61K47/10; A61K47/12; A61K47/14; A61K47/18; A61K47/20; A61K47/24; A61K47/26; A61K47/32; A61K47/36; A61K47/38; A61K47/40; A61P35/00
Foreign References:
| WO2017035753A1 | ||||
| CN107176954A |
Attorney, Agent or Firm:
Aoki Atsushi
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Ryotaro Takei
Kazumi Nakamura
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Ryotaro Takei
Kazumi Nakamura